CroiValve Cardiac Valve Prosthetic with Anti-Migration Features US20260096878A1
Summary
CroiValve Patent A1, Apr 9, Cardiac Valve Treatment
What changed
USPTO Publication US20260096878A1 discloses a patent application by CroiValve Ltd. covering apparatus and methods for repairing a defective cardiac valve, such as the tricuspid valve, with anti-migration features. The prosthetic device is coupled to an elongated support and stent configured for implantation in the superior vena cava, with features to resist migration and prevent in-folding during deployment.
Medical device manufacturers and healthcare providers should note that the published application establishes intellectual property protection for cardiac valve treatment technology. The device remains in the development stage and is not yet market-authorized. Companies developing competing transcatheter valve technologies should review the claims for potential design-around opportunities, while investors should monitor ongoing patent prosecution as an indicator of the company's IP portfolio strength.
What to do next
- Monitor for updates on patent prosecution status
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYSTEMS AND METHODS FOR TREATING A DEFECTIVE CARDIAC VALVE HAVING ANTIMIGRATION FEATURES
Application US20260096878A1 Kind: A1 Apr 09, 2026
Assignee
CroiValve Ltd.
Inventors
Vincent HULK, Gavin KENNY, Pascal LAUNOIS, Ricky UNADKAT, Amit TUBISHEVITZ
Abstract
Apparatus and methods for repairing a cardiac valve, e.g., a tricuspid valve, are provided. The apparatus may include a prosthetic device coupled to an elongated support coupled to a stent configured to be implanted within a vessel, e.g., the superior vena cava, to suspend and maintain the prosthetic device within the cardiac valve. The support may include a proximal, delivery portion detachably coupled, in a delivery state, to a distal, implantable portion coupled to the prosthetic device. The prosthetic device may be formed of biocompatible material coupled to a frame, and may have prosthetic leaflets that allows blood to flow therethrough in one direction during diastole, but prevents blood regurgitation during systole. The stent further may include features configured to resist migration of the stent within the vessel, as well as to prevent in-folding of the stent during deployment.
CPC Classifications
A61F 2/2412 A61F 2/2427 A61F 2220/0008 A61F 2230/0006 A61F 2230/001 A61F 2250/0018 A61F 2250/0039
Filing Date
2025-09-19
Application No.
19333867
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.